Integrin αvβ3 is known to be involved in vascular endothelial cell recruitment and tumor vascularization.[54, 55] Surprisingly, the 3D sgECAD tumors exhibited more CD31‐labeled vascular endothelial cells, which disappeared after Cilengitide coadministration (Figure 7F). This evidence concerns the gene PECAM1 and neoplasm.